956878.fig.001a
(a)
956878.fig.001b
(b)
956878.fig.001c
(c)
956878.fig.001d
(d)
956878.fig.001e
(e)
Figure 1: Levels of sHLA-E, sHLA-F, chromogranin, and calprotectin are increased in NB patients. Concentrations of sHLA-E (a), sHLA-F (b), chromogranin (c), calprotectin (d), and B7H3 (e) measured in samples from NB patients (black dots) or healthy children (HC, white dots). Results are expressed as arbitrary units/mL for sHLA-E, sHLA-F, and B7H3, pg/mL for chromogranin and ng/mL for calprotectin. Horizontal bars indicated medians. values are indicated where the difference is statistically significant.